Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Reducing the CV Risks of Smoking
10
Mins
December 2024
Smoking is a major risk factor for cardiovascular disease (CVD) and responsible for around 25% of all CVD-related deaths worldwide…
Read more
6
Mins
23 Jun 2020
Data from the AUGUSTUS Trial Adds an Important Piece to the Complex Puzzle of Antithrombotic Treatment for Those with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention
AF can increase stroke risk and is generally treated with OAC therapy, such as with a VKA or a direct OAC (DOAC). However, what if someone with AF…
8
Mins
23 Jun 2020
Oral Prostacyclin Pathway Agents in Pulmonary Arterial Hypertension: An Expert Clinical Consensus
PAH is a rare, progressive disorder with a number of aetiologies. Approximately 15–60 patients per million of the global population are affected…
8
Mins
23 Jun 2020
Editor’s Pick: Bone-Related Markers of Cardiovascular Disease
Vascular calcification is an independent risk factor for cardiovascular disease (CVD). Calcium deposits in coronary arteries can weaken vasomotor…
2
Mins
15 Jun 2020
Safety and Efficacy of Mavacamten in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: The MAVERICK-HCM Study
Hypertrophic cardiomyopathy (HCM) is a progressive primary myocardial disorder characterised by unexplained left ventricular…
6
Mins
1 Jun 2020
Case Report: Inhaled Nitroglycerine as an Alternative to Inhaled Nitric Oxide in the Acute Treatment of Pulmonary Hypertension and Impending Acute Right Ventricular Failure in the Intensive Care Unit
Pulmonary hypertension as a cause of right-sided heart failure and shock is often missed. In the intensive care patient population…
11
Mins
31 Mar 2020
Managing Heart Disease in Pregnancy
Cardiovascular diseases complicate approximately 0.2–4.0% of pregnancies.1 Their incidence is increasing…
9
Mins
12 Dec 2019
Clustering by Health Professionals in Individually Randomised Controlled Trials
Researchers that individually randomised controlled trials (iRCT) assume that the observed outcomes of participants…
6
Mins
12 Dec 2019
Cardiovascular Complications in Pre-eclampsia: Can they be Predicted Electrocardiographically?
This study aimed to investigate the role of ECG in pre-eclampsia diagnostics and simple clinical parameters in pre-eclampsia patients with and without…
Loading posts...
« Previous
1
…
10
11
12
13
14
…
24
Next »